Barbara D Reed1, Laurie J Legocki, Melissa A Plegue, Ananda Sen, Hope K Haefner, Sioban D Harlow. 1. Department of Family Medicine, the Center for Statistical Consultation and Research, the Department of Biostatistics, School of Public Health, the Department of Obstetrics and Gynecology, and the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.
Abstract
OBJECTIVE: To assess incidence rates of and risk factors for vulvodynia. METHODS: We conducted a longitudinal population-based study of women in southeast Michigan (Woman-to-Woman Health Study) using a validated survey-based screening test for vulvodynia that was repeated at 6-month intervals over 30 months. Unadjusted incidence rates were determined using Poisson models. Demographic and symptom-related risk factors for incidence were assessed using discrete time survival analysis. RESULTS: Women who screened negative for vulvodynia at baseline and were followed through at least one additional survey (n=1,786) were assessed for onset of vulvodynia. The incidence rate was 4.2 cases per 100 person-years, and rates per 100 person-years were greater in women who were younger (7.6 cases per 100 person-years at age 20 years, compared with 3.3 cases per 100 person-years at age 60 years), Hispanic (9.5 cases per 100 person-years), married, or living as married (4.9 cases per 100 person-years); had reported symptoms of vulvar pain but did not meet vulvodynia criteria on the initial survey (11.5 cases per 100 person-years); or had reported past symptoms suggesting a history of vulvodynia (7.5 cases per 100 person-years). Increased risk of new-onset vulvodynia also included baseline sleep disturbance, chronic pain in general, specific comorbid pain disorders, and specific comorbid psychological disorders. CONCLUSIONS: The incidence rates of vulvodynia differ by age, ethnicity, and marital status. Onset is more likely among women with previous symptoms of vulvodynia or those with intermediate symptoms not meeting criteria for vulvodynia and among those with pre-existing sleep, psychological, and comorbid pain disorders. This suggests vulvodynia is an episodic condition with a potentially identifiable prodromal phase. LEVEL OF EVIDENCE: II.
OBJECTIVE: To assess incidence rates of and risk factors for vulvodynia. METHODS: We conducted a longitudinal population-based study of women in southeast Michigan (Woman-to-Woman Health Study) using a validated survey-based screening test for vulvodynia that was repeated at 6-month intervals over 30 months. Unadjusted incidence rates were determined using Poisson models. Demographic and symptom-related risk factors for incidence were assessed using discrete time survival analysis. RESULTS:Women who screened negative for vulvodynia at baseline and were followed through at least one additional survey (n=1,786) were assessed for onset of vulvodynia. The incidence rate was 4.2 cases per 100 person-years, and rates per 100 person-years were greater in women who were younger (7.6 cases per 100 person-years at age 20 years, compared with 3.3 cases per 100 person-years at age 60 years), Hispanic (9.5 cases per 100 person-years), married, or living as married (4.9 cases per 100 person-years); had reported symptoms of vulvar pain but did not meet vulvodynia criteria on the initial survey (11.5 cases per 100 person-years); or had reported past symptoms suggesting a history of vulvodynia (7.5 cases per 100 person-years). Increased risk of new-onset vulvodynia also included baseline sleep disturbance, chronic pain in general, specific comorbid pain disorders, and specific comorbid psychological disorders. CONCLUSIONS: The incidence rates of vulvodynia differ by age, ethnicity, and marital status. Onset is more likely among women with previous symptoms of vulvodynia or those with intermediate symptoms not meeting criteria for vulvodynia and among those with pre-existing sleep, psychological, and comorbid pain disorders. This suggests vulvodynia is an episodic condition with a potentially identifiable prodromal phase. LEVEL OF EVIDENCE: II.
Authors: Barbara Gardella; Daniele Porru; Rossella E Nappi; Maria Diletta Daccò; Alessia Chiesa; Arsenio Spinillo Journal: J Sex Med Date: 2011-04-07 Impact factor: 3.802
Authors: Jocelyn T Sutton; Gloria A Bachmann; Lauren D Arnold; George G Rhoads; Raymond C Rosen Journal: J Womens Health (Larchmt) Date: 2008-10 Impact factor: 2.681
Authors: Barbara D Reed; Siobán D Harlow; Ananda Sen; Rayna M Edwards; Di Chen; Hope K Haefner Journal: Obstet Gynecol Date: 2012-07 Impact factor: 7.661
Authors: M J Tribó; O Andión; S Ros; M Gilaberte; F Gallardo; A Toll; M Ferrán; A Bulbena; R M Pujol; J E Baños Journal: Dermatology Date: 2008 Impact factor: 5.366
Authors: Noam Smorgick; Courtney A Marsh; Sawsan As-Sanie; Yolanda R Smith; Elisabeth H Quint Journal: J Pediatr Adolesc Gynecol Date: 2013-03-16 Impact factor: 1.814
Authors: J Curtis Nickel; Dean A Tripp; Michel Pontari; Robert Moldwin; Robert Mayer; Lesley K Carr; Raggi Doggweiler; Claire C Yang; Nagendra Mishra; Jorgen Nordling Journal: J Urol Date: 2010-01 Impact factor: 7.450
Authors: Ellen A Schur; Niloofar Afari; Helena Furberg; Megan Olarte; Jack Goldberg; Patrick F Sullivan; Dedra Buchwald Journal: J Gen Intern Med Date: 2007-06 Impact factor: 5.128
Authors: Candi C Bachour; Gloria A Bachmann; David C Foster; Jim Y Wan; Leslie A Rawlinson; Candace S Brown Journal: Clin Trials Date: 2016-08-11 Impact factor: 2.486
Authors: L Elaine Waetjen; Sybil L Crawford; Po-Yin Chang; Barbara D Reed; Rachel Hess; Nancy E Avis; Sioban D Harlow; Gail A Greendale; Sheila A Dugan; Ellen B Gold Journal: Menopause Date: 2018-10 Impact factor: 2.953
Authors: Megan L Falsetta; David C Foster; Collynn F Woeller; Stephen J Pollock; Adrienne D Bonham; Constantine G Haidaris; Richard P Phipps Journal: J Pain Date: 2016-08-18 Impact factor: 5.820
Authors: Dimitrios Papoutsis; Hope K Haefner; Christopher P Crum; Anthony W Opipari; Barbara D Reed Journal: J Low Genit Tract Dis Date: 2016-07 Impact factor: 1.925
Authors: Barbara D Reed; Kimberly S McKee; Melissa A Plegue; Sung Kyun Park; Hope K Haefner; Sioban D Harlow Journal: J Womens Health (Larchmt) Date: 2018-10-10 Impact factor: 2.681